Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

LORAZEPAM

SANIS HEALTH INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is LORAZEPAM discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that LORAZEPAM 2.0MG has been permanently discontinued (last updated February 6, 2022). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is LORAZEPAM not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file3 products · 1 same form & route
Affected strength2.0MG
Report last updated2022-02-06
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

PRO-LORAZEPAM

PRO DOC LIMITEE

1MG · DIN 00655651

Different strengthSame dosage formSame routeNo current shortage

LORAZEPAM INJECTION USP

SANDOZ CANADA INCORPORATED

4MG · DIN 02243278

Different strengthDifferent dosage formDifferent routeNo current shortage

LORAZEPAM INJECTION, USP

FRESENIUS KABI CANADA LTD

4MG · DIN 02550962

Different strengthDifferent dosage formDifferent routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02351099

Strength

2.0MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

LORAZEPAM

Tier

Unrated

Last Updated

2022-02-06

Reason for Shortage

Business reasons

Past Reports for This Drug

LORAZEPAM has 2 shortage/discontinuation reports on file — this is one of them.